Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Equipment
Datasets
Search by expertise, name or affiliation
Refined testing and targeted therapy lead new fight against prostate cancer
William J. Catalona
*
*
Corresponding author for this work
Urology
Research output
:
Contribution to journal
›
Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Refined testing and targeted therapy lead new fight against prostate cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
INIS
prostate
100%
cancer
60%
antigens
60%
testing
40%
patients
40%
screening
40%
organs
40%
interventions
40%
tools
20%
therapy
20%
detection
20%
biopsy
20%
malignancies
20%
radiotherapy
20%
accuracy
20%
Medicine and Dentistry
Prostate Specific Antigen
60%
Prostate Cancer
40%
Patient
40%
Therapeutic Procedure
40%
Organ
40%
Radiation Therapy
20%
Serum
20%
Prostatectomy
20%
Screening
20%
Malignant Neoplasm
20%
False Positive Result
20%
Mental Stress
20%
Cancer
20%
Targeted Therapy
20%
Accuracy
20%
Biopsy
20%
Lead
20%
Cancer Screening
20%
Fighting
20%